74 related articles for article (PubMed ID: 1590375)
1. Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody.
Reinke M
Am J Physiol; 1992 May; 262(5 Pt 1):E658-62. PubMed ID: 1590375
[TBL] [Abstract][Full Text] [Related]
2. Enzyme immunoassay of human plasma 11-dehydrothromboxane B2.
Takasaki W; Nakagawa A; Tanaka Y; Nakamura K; Shindo H; Hayashi Y; Yamamoto S
Thromb Res; 1991 Aug; 63(3):331-41. PubMed ID: 1957275
[TBL] [Abstract][Full Text] [Related]
3. Development of an enzyme-linked immunosorbent assay of thromboxane B2 using a monoclonal antibody.
Reinke M; Piller M; Brune K
Prostaglandins; 1989 May; 37(5):577-86. PubMed ID: 2740526
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane B2 and 11-dehydrothromboxane B2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
Uedelhoven WM; Meese CO; Weber PC
J Chromatogr; 1989 Dec; 497():1-16. PubMed ID: 2625446
[TBL] [Abstract][Full Text] [Related]
5. Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay.
Hayashi Y; Shono F; Yamamoto S; Takasaki W; Nakagawa A; Watanabe K; Yamashita K; Miyazaki H
Anal Biochem; 1990 May; 187(1):151-9. PubMed ID: 2372112
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal anti-thromboxane B2 antibody.
Reinke M; Brune K
FEBS Lett; 1988 May; 232(1):46-50. PubMed ID: 3130275
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma and urinary 11-dehydrothromboxane B2 in healthy subjects produced by oral CS-518, a novel thromboxane synthase inhibitor.
Uematsu T; Takasaki W; Kosuge K; Wada K; Matsuno H; Tanaka Y; Yamamura N; Nakashima M
Eur J Clin Pharmacol; 1993; 45(3):283-6. PubMed ID: 8276056
[TBL] [Abstract][Full Text] [Related]
8. Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.
Olson MT; Kickler TS; Lawson JA; McLean RC; Jani J; FitzGerald GA; Rade JJ
J Thromb Haemost; 2012 Dec; 10(12):2462-9. PubMed ID: 23072449
[TBL] [Abstract][Full Text] [Related]
9. Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.
Perneby C; Granström E; Beck O; Fitzgerald D; Harhen B; Hjemdahl P
Thromb Res; 1999 Dec; 96(6):427-36. PubMed ID: 10632465
[TBL] [Abstract][Full Text] [Related]
10. Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels.
Gonçalves LH; Silva MV; Duarte RC; Dusse LM; Fernandes AP; Bosco AA; Gomes KB; Carvalho Md
Clin Chim Acta; 2014 Feb; 429():76-8. PubMed ID: 24316050
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay for plasma thromboxane B2.
McCann DS; Tokarsky J; Sorkin RP
Clin Chem; 1981 Aug; 27(8):1417-20. PubMed ID: 7273401
[TBL] [Abstract][Full Text] [Related]
12. Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis?
Varnell CD; Goldstein SL; Yee DL; Teruya J; Guyer KE; Siddiqui S; Jefferies JL
Pediatr Blood Cancer; 2014 Nov; 61(11):2074-6. PubMed ID: 24803308
[TBL] [Abstract][Full Text] [Related]
13. Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor.
Takasaki W; Nakagawa A; Asai F; Ushiyama S; Sugidachi A; Matsuda K; Oshima T; Tanaka Y
Thromb Res; 1993 Jul; 71(1):69-76. PubMed ID: 8367836
[TBL] [Abstract][Full Text] [Related]
14. Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay.
Anhut H; Peskar BA; Bernauer W
Naunyn Schmiedebergs Arch Pharmacol; 1978 Dec; 305(3):247-52. PubMed ID: 740052
[No Abstract] [Full Text] [Related]
15. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
Ciabattoni G; Maclouf J; Catella F; FitzGerald GA; Patrono C
Biochim Biophys Acta; 1987 Apr; 918(3):293-7. PubMed ID: 3567215
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-immunoassay of thromboxane B2 at the picogram level.
Sawada M; Inagawa T; Frölich JC
Prostaglandins; 1985 Jun; 29(6):1039-48. PubMed ID: 3929333
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay.
Wu P; Fritzo M; Tai HH
Biochim Biophys Acta; 1990 Oct; 1036(1):55-63. PubMed ID: 2223826
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay for 11-dehydro-TXB2: a method for monitoring thromboxane production in vivo.
Kumlin M; Granström E
Prostaglandins; 1986 Nov; 32(5):741-67. PubMed ID: 3823488
[TBL] [Abstract][Full Text] [Related]
19. Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay.
Riutta A; Mucha I; Vapaatalo H
Anal Biochem; 1992 May; 202(2):299-305. PubMed ID: 1519756
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients].
Muramatsu H; Kotajima R; Sato T
Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
